Replimune Group, Inc. — Director's Dealing 2020

Dec 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-12-23

Reporting Person: Esposito Pamela (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-23	Common Stock	M	50704	$1.75	Acquired	175994	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-23	Employee Stock Option (right to buy)	$1.75	M	50704	Disposed	2026-03-01	Common Stock (50704)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vested on February 28, 2017 and the remainder of the shares underlying this stock option vested in 36 approximately equal monthly installments thereafter.